Plasma Treatment Limits Cutaneous Squamous Cell Carcinoma Development In Vitro and In Vivo

Plasma Treatment Limits Cutaneous Squamous Cell Carcinoma Development In Vitro and In Vivo

Cutaneous squamous cell carcinoma (SCC) is the most prevalent cancer worldwide, increasing the cost of healthcare services and with a high rate of morbidity. Its etiology is linked to chronic ultraviolet (UV) exposure that leads to malignant transformation of keratinocytes. Invasive growth and metas...

Full description

Bibliographic Details
Main Authors: Gabriella Pasqual-Melo, Thiago Nascimento, Larissa Juliani Sanches, Fernanda Paschoal Blegniski, Julya Karen Bianchi, Sanjeev Kumar Sagwal, Julia Berner, Anke Schmidt, Steffen Emmert, Klaus-Dieter Weltmann, Thomas von Woedtke, Rajesh Kumar Gandhirajan, Alessandra Lourenço Cecchini, Sander Bekeschus
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
kINPen
plasma medicine
plasma sources
reactive oxygen and nitrogen species
cutaneous squamous cell carcinoma (SCC)
Online Access:https://www.mdpi.com/2072-6694/12/7/1993

Similar Items

Similar Items